| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
9 companies
Armistice Capital, LLC serves as a 10% Owner at HIND and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 337 buys and 114 sells. Those positions are worth an estimated $10.1M at current prices.
Historically, Armistice Capital, LLC's trades have earned a middling insider score of 56/100 across 42 rated trades. Over a 12-month horizon, 23.8% of those trades were profitable, with an average 12-month return of -33.4%.
The biggest single holding is ACHV (~$3.7M) as 10% Owner. The recent filings there lean toward selling, a net 299,332 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 15,000 | $4.81 | $72,150.00 | - | |
| May 31, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 51,000 | $4.71 | $240,176.00 | +0.3% | |
| May 28, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 29,000 | $5.02 | $145,539.00 | +0.2% | |
| May 17, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 10,000 | $5.18 | $51,823.64 | - | |
| May 14, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 20,000 | $4.97 | $99,312.18 | +0.1% | |
| Mar 29, 2019 | KPRX Kiora Pharmaceuticals Inc | Director, 10% Owner | Buy | 549,647 | $0.32 | $175,216.45 | +3.2% | |
| Mar 27, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 50,000 | $5.47 | $273,299.04 | +0.3% | |
| Mar 8, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 374,486 | $5.50 | $2,059,313.95 | +2.1% | |
| Jan 18, 2019 | BPTH Bio-Path Holdings, Inc. | 10% Owner | Sell | 64,457 | $2.66 | $171,642.55 | -33.3% | |
| Jan 11, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 13,996 | $3.88 | $54,335.40 | - |